Ketamine Clinics in Philadelphia, PA
Browse 12 ketamine therapy providers in Philadelphia, Pennsylvania.
Better Health Whole Wellness Center
1638 Pine Street, 1st Floor
Philadelphia,
PA
19103
Lori Goldstein, MD Psychiatry
1601 Walnut Street, Suite 815
Philadelphia,
PA
19102
Mindstream Medicine
2418 East York St.
Philadelphia,
PA
19125
Einstein Physicians Practice Plan, Inc
5501 Old York Rd
Philadelphia,
PA
19141
Albert Einstein Medical Cent
5501 OLD YORK RD
Philadelphia,
PA
19141
Elwyn
12 N Preston St
Philadelphia,
PA
19104
Nurowav Tms
1608 Walnut Street Suite 1101
Philadelphia,
PA
19103
Axon Psychiatry Of Philadelphia
3300 HENRY AVE STE 112
Philadelphia,
PA
19129
Marie Sims
3300 Henry Ave Okami Collective Suite 364
Philadelphia,
PA
19129
One Stop Wellness Md
1500 Walnut St Ste 1051
Philadelphia,
PA
19102
University Of Pennsylvania Psychiatry Outpatient Clinic
3535 MARKET ST
Philadelphia,
PA
19104
Bruce Saltzman
1638 PINE ST
Philadelphia,
PA
19103
Ketamine Treatments in Philadelphia
Explore ketamine treatment options available in Philadelphia, Pennsylvania.
IV Ketamine Infusion
Off-label psychiatric use. Verify protocols, evidence, risks, and pricing with the provider.
IM Injection
Off-label psychiatric use. Availability and clinical protocols vary by provider.
Spravato (Esketamine)
FDA-approved nasal spray administered in a REMS-certified healthcare setting.
Ketamine-Assisted Psychotherapy
Off-label and still under study. Evidence, training, and protocols vary.
Compare source evidence in Philadelphia, Pennsylvania
These 12 directory records are starting points for checking providers. 9 carry an imported Spravato REMS flag and 3 come from ASKP membership data. Neither an NPI entry nor association membership confirms a particular therapy, current intake, price or suitability.
No additional provider-site service check has been recorded for this city cohort. Confirm each listed service directly.
Questions before choosing a service
- Which exact medicine, formulation and route does this location offer? Distinguish Spravato from other ketamine products.
- Who evaluates eligibility, and how can you verify that clinician’s state licence?
- What observation, follow-up and urgent-care arrangements does the provider explain?
- What does the written total include: evaluation, medicine, monitoring, follow-up and any facility fee? Confirm coverage with your insurer.
FDA maintains compounding risk alerts, including its ketamine alerts. Read the current product information and discuss risks and alternatives with your treating clinician. Directory inclusion is not a treatment recommendation or a guarantee of availability.
Directory sources and limits · Spravato information · Questions and treatment distinctions